MX355668B - Uso de un extracto de mirto como un agente anti-biopelicula contra propionibacterium acnes. - Google Patents

Uso de un extracto de mirto como un agente anti-biopelicula contra propionibacterium acnes.

Info

Publication number
MX355668B
MX355668B MX2015000276A MX2015000276A MX355668B MX 355668 B MX355668 B MX 355668B MX 2015000276 A MX2015000276 A MX 2015000276A MX 2015000276 A MX2015000276 A MX 2015000276A MX 355668 B MX355668 B MX 355668B
Authority
MX
Mexico
Prior art keywords
acnes
agent against
myrtle extract
biofilm agent
biofilm
Prior art date
Application number
MX2015000276A
Other languages
English (en)
Other versions
MX2015000276A (es
Inventor
Luc Joelle
Fiorini-Puybaret Christel
Original Assignee
Fabre Pierre Dermo Cosmetique
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fabre Pierre Dermo Cosmetique filed Critical Fabre Pierre Dermo Cosmetique
Publication of MX2015000276A publication Critical patent/MX2015000276A/es
Publication of MX355668B publication Critical patent/MX355668B/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/61—Myrtaceae (Myrtle family), e.g. teatree or eucalyptus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/12—Ketones
    • A61K31/122—Ketones having the oxygen directly attached to a ring, e.g. quinones, vitamin K1, anthralin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9783—Angiosperms [Magnoliophyta]
    • A61K8/9789—Magnoliopsida [dicotyledons]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/10—Anti-acne agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Mycology (AREA)
  • Botany (AREA)
  • Microbiology (AREA)
  • Dermatology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Medical Informatics (AREA)
  • Birds (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Cosmetics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

La presente invención se refiere a una composición dermatológica que contiene un extracto de mirto a una concentración que es mayor que o igual a 0.01% en peso, para el uso del misma como un agente anti-biopelícula contra Propionibacterium acnes.
MX2015000276A 2012-07-09 2013-07-08 Uso de un extracto de mirto como un agente anti-biopelicula contra propionibacterium acnes. MX355668B (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR1256607A FR2992862B1 (fr) 2012-07-09 2012-07-09 Utilisation d'un extrait de myrte en tant qu'agent anti-biofilm vis-a-vis de p. acnes
PCT/EP2013/064415 WO2014009325A1 (fr) 2012-07-09 2013-07-08 Utilisation d'un extrait de myrte en tant qu'agent anti-biofilm vis-a-vis de p. acnes

Publications (2)

Publication Number Publication Date
MX2015000276A MX2015000276A (es) 2015-07-21
MX355668B true MX355668B (es) 2018-04-24

Family

ID=47022816

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2015000276A MX355668B (es) 2012-07-09 2013-07-08 Uso de un extracto de mirto como un agente anti-biopelicula contra propionibacterium acnes.

Country Status (9)

Country Link
US (1) US9808496B2 (es)
EP (1) EP2869827B1 (es)
JP (1) JP2015522054A (es)
BR (1) BR112015000275B1 (es)
CA (1) CA2878496C (es)
ES (1) ES2635382T3 (es)
FR (1) FR2992862B1 (es)
MX (1) MX355668B (es)
WO (1) WO2014009325A1 (es)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BRPI0811530B1 (pt) 2007-05-14 2019-01-02 Research Foundation Of State Univ Of New York composição compreendendo indutor(es) de resposta fisiológica à dispersão ácido decanóico, superfície, solução, método ex vivo de tratamento ou inibição da formação de um biofilme sobre uma superfície
AU2016389266B2 (en) 2016-01-28 2021-07-01 Kimberly-Clark Worldwide, Inc. Anti-adherent composition against DNA viruses and method of inhibiting the adherence of DNA viruses to a surface
KR102627187B1 (ko) 2016-05-26 2024-01-22 킴벌리-클라크 월드와이드, 인크. 유착 방지 조성물 및 표면에 대한 미생물의 유착을 억제하는 방법
US11541105B2 (en) 2018-06-01 2023-01-03 The Research Foundation For The State University Of New York Compositions and methods for disrupting biofilm formation and maintenance
FR3120790B1 (fr) * 2021-03-10 2024-03-15 Fabre Pierre Dermo Cosmetique Association d’un extrait de myrte et d’un extrait de Tripterygium wilfordii pour lutter contre l’inflammation induite par C. acnes
FR3132632B1 (fr) 2022-02-17 2025-05-23 Fabre Pierre Dermo Cosmetique Composition comprenant un extrait de myrte et un extrait de Tripterygium wilfordii pour lutter contre l’acné des zones non lésionnelles de la peau acnéique
CN116763692A (zh) * 2023-05-26 2023-09-19 广州凡岛网络科技有限公司 一种控油祛痘组合物及其应用

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2783425B1 (fr) 1998-09-17 2002-06-07 Fabre Pierre Dermo Cosmetique Extrait de myrte titre en myrtucommulone b', son procede de preparation et son application en dermatologie et en cosmetologie
US20060008538A1 (en) * 2004-07-07 2006-01-12 Wu Jeffrey M Methods of treating the skin
US9254257B2 (en) * 2010-10-21 2016-02-09 Cadila Healthcare Limited Method for treatment of acne using pharmaceutical compositions of clindamycin

Also Published As

Publication number Publication date
JP2015522054A (ja) 2015-08-03
ES2635382T3 (es) 2017-10-03
WO2014009325A1 (fr) 2014-01-16
US20150190447A1 (en) 2015-07-09
EP2869827A1 (fr) 2015-05-13
EP2869827B1 (fr) 2017-05-03
FR2992862B1 (fr) 2014-10-03
CA2878496C (fr) 2020-12-15
MX2015000276A (es) 2015-07-21
BR112015000275B1 (pt) 2021-02-09
BR112015000275A2 (pt) 2017-06-27
US9808496B2 (en) 2017-11-07
FR2992862A1 (fr) 2014-01-10
CA2878496A1 (fr) 2014-01-16

Similar Documents

Publication Publication Date Title
MX2016016666A (es) Derivados de acido boronico y usos terapeuticos de los mismos.
MX2016015093A (es) Derivados de acido boronico y sus usos terapeuticos.
MX2015008627A (es) Derivados de acido boronico y usos terapeuticos de los mismos.
MX2015008628A (es) Derivados de acido boronico y usos terapeuticos de los mismos.
PH12016501151A1 (en) Nrf2 regulators
MX355668B (es) Uso de un extracto de mirto como un agente anti-biopelicula contra propionibacterium acnes.
MX2017004838A (es) Composiciones de interleucina-15 y usos de estas.
MX2016011898A (es) Composiciones de compuestos selenoorganicos y metodos de uso de los mismos.
PH12016500511A1 (en) Selective grp94 inhibitors and uses thereof
MX2015011897A (es) Profarmacos de fumaratos y su uso en el tratamiento de diferentes enfermedades.
NZ712270A (en) Pharmaceutical composition of s-ketamine hydrochloride
PH12015500900B1 (en) A stabilized pemetrexed formulation
PH12018500446A1 (en) Pyridinone dicarboxamide for use as bromodomain inhibitors
NZ702930A (en) Racecadotril liquid compositions
PH12017500836A1 (en) Transdermal formulations
MX362879B (es) Usos novedosos.
BR112014002940A2 (pt) uso e composição agroquímica de dibutilamidas de ácido carboxílico
MX2018016290A (es) Agente antidesgaste.
IN2014DN07326A (es)
MY203626A (en) Compositions and methods for inhibiting the biological activity of soluble biomolecules
IN2014DN11078A (es)
PH12017500348A1 (en) Tetrahydroquinoline derivatives as bromodomain inhibitors
MX370990B (es) Ésteres de ácidos oligo-hidroxicarboxílicos y uso de los mismos.
MY193776A (en) Modified cytotoxins and their therapeutics use
PH12016501814A1 (en) Inhibitors of the wnt signalling pathways

Legal Events

Date Code Title Description
FG Grant or registration